December 10, 2007 |
|
MOLOGEN AG submits application for clinical studies with innovative cancer treatment dSLIM®
 more
|
November 14, 2007 |
|
MOLOGEN AG announces results for the first nine months of 2007
more
|
September 24, 2007 |
|
MOLOGEN AG: Patent for MIDGE-based vaccine against Leishmaniasis will be granted.
more
|
August 14, 2007 |
|
MOLOGEN AG reports results of first six months 2007.
more
|
August 08, 2007 |
|
MOLOGEN AG: Treatment permission granted for cancer therapy in India
more
|
June 04, 2007 |
|
MOLOGEN AG sets course for sustainable success
more
|
June 01, 2007 |
|
MOLOGEN AG sells Spanish subsidiary
more
|
May 15, 2007 |
|
MOLOGEN AG invests into pre-clinical studies in the first quarter of 2007
more
|
April 24, 2007 |
|
MOLOGEN AG launches new company website
more
|
March 29, 2007 |
|
MOLOGEN AG reports profit for fiscal year 2006
· 2006 most successful year in company history
· Multiplication of sales through
commercialization agreements
more
|
March 15, 2007 |
| MOLOGEN AG: Successful capital increase to finance clinical studies
more |
March 12, 2007 |
| MOLOGEN AG: Patent granted for innovative technology in China
more
further Informations about Leishmaniasis |
February 01, 2007 |
| MOLOGEN AG appoints new Chief Financial Officer
more |
January 08, 2007 |
| MOLOGEN AG to upscale and optimize production
of DNA molecule
more |
January 02, 2007
|
| MOLOGEN AG acquires innovative technology
more |
December 29, 2006 |
| MOLOGEN AG out-licenses marketing rights for India
and receives further upfront payment
more |
December 27, 2006 |
| MOLOGEN AG receives upfront payment
more |
December 06, 2006 |
| MOLOGEN AG: Abu Dhabi health authorities do not
grant permission for patient treatment
more |
December 05, 2006 |
| MOLOGEN AG with new major shareholder
SALVATOR Asset Management crosses 5-percent threshold
more |
November 09, 2006 |
| MOLOGEN AG announces results of first nine months
2006 and out-licensing agreement for Asia
more |
October 25, 2006 |
| MOLOGEN AG receives Orphan Drug status for cell based gene therapy for renal cell cancer
more |
October 18, 2006
|
| MOLOGEN AG: Basic patent legally valid in Europe
more |
September 22, 2006
|
| MOLOGEN AG will receive patent for new technological
variant of MIDGE
more |
September 20, 2006
|
| MOLOGEN AG: Exclusivity for Cell-based Cancer
Treatment
more |
August 14, 2006
|
| MOLOGEN AG will receive patent for technological
variant of MIDGE
more |
August 10, 2006
|
| MOLOGEN closes second quarter of 2006:
Important contracts closed and good prospects although revenues still
low
Ad-hoc-Mitteilung more
Press Releases more
 Half-year Report 2006
download |
August 07, 2006
|
| MOLOGEN AG: Patent for DNA based vaccine against
important cat disease granted
more |
August 04, 2006
|
| MOLOGEN’s MIDGE vector wins "Frost
& Sullivan’s 2006 Technology Innovation of the Year Award"
Laudatio 2006
download |
June 08, 2006
|
| EMEA grants MOLOGEN AG medicine status for their
cell-based gene therapy
more |
June 08, 2006
|
| Annual Meeting of the MOLOGEN AG
more |
May 11, 2006
|
| MOLOGEN AG closes strategically successful first
quarter 2006
more |
April 27, 2006
|
| Major MOLOGEN shareholder increases investment
more
Further
information on Leishmaniasis |
April 19, 2006
|
| Major MOLOGEN shareholder increases investment
more |
March 30, 2006
|
| MOLOGEN supplies Emirates with Tumor Therapy
more |
March 29, 2006
|
| MOLOGEN presents overall result for the year:
Successful projects and sound financing provide solid basis for future
growth
more
Consolidated Financial
Report 2005 IFRS download |
March 06, 2006
|
| MOLOGEN's technological advancements enhance license
business potential. Strategic focus concentrated through termination of
Arab joint venture
more |
Febuary 20, 2006
|
|
MOLOGEN reviews extensive license agreement on
tumor therapy in India
more |
December 21, 2005
|
| Regulatory authority’s notification shortens
preparation period for dSLIM clinical studies
more
|
December 12, 2005
|
| MOLOGEN AG was granted European patent MIDGE-TH1
more
|
November 11, 2005
|
| MOLOGEN: MIDGE-TH1 patent will be granted in Europe
more
|
November 10, 2005
|
| MOLOGEN submits report on third quarter: The course
is set on a positive future
more
|
October 12, 2005
|
| MOLOGEN AG raises funds for clinical trials by
increasing share capital
more
|
September 30, 2005
|
| MOLOGEN AG strengthened liquidity by successful
capital increase
more
|
September 22, 2005
|
| MOLOGEN receives manufacturing authorisation for
a DNA vaccine
more
|
August 11, 2005
|
| MOLOGEN strengthens basis for positive business
development with non-recurring expenditure. Positive prognosis for the
remaining year
Ad-hoc-Mitteilung more
Press Releases more
Half-year Report 2005 
download
|
July 21, 2005
|
| MOLOGEN AG adapts executive board structure to
future growth. Company expands board to three members, appoints new chief
financial officer
more
|
PRESS
RELEASES 
